These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4930810)

  • 41. [The influence of Mycobacterium bovis BCG-Prague, respectively of Mycobacterium smegmatis on the growth of the intratracheally transplanted Deal's sarcoma in guinea pigs (author's transl)].
    Schwartz E; Vincúrová M; Badalík L
    Bratisl Lek Listy; 1975 Sep; 64(3):272-84. PubMed ID: 1100201
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
    Taniyama T; Azuma I; Aladin AA; Yamamura Y
    Gan; 1975 Dec; 66(6):705-9. PubMed ID: 817955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peptidoglycan adjuvants: minimal structure required for activity.
    Adam A; Ellouz F; Ciorbaru R; Petit JF; Lederer E
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):341-8. PubMed ID: 126566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Biological activities of bacterial cell wall peptidoglycans and their subunits, with special reference to the immunoadjuvant actions (author's transl)].
    Kotani S
    Seikagaku; 1976; 48(12):1081-107. PubMed ID: 799719
    [No Abstract]   [Full Text] [Related]  

  • 45. Cross reactivity of Mycobacterium laprae and BCG. A report on further studies.
    Goihman-Yahr M; Convit J
    Int J Lepr Other Mycobact Dis; 1972; 40(1):62-7. PubMed ID: 4562385
    [No Abstract]   [Full Text] [Related]  

  • 46. [Study of immunobiological properties of specific immunomodulators of the adjuvant type in experimental tuberculosis].
    Gorelova LA; Zemskova ZS; Panasek IA; Nekrasov AV; Puchkova NG; Moroz AM; Romanova RIu
    Probl Tuberk; 1996; (3):46-7. PubMed ID: 8754882
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunotherapy of cancer: tumor suppression and regression by cell walls of Mycobacterium phlei attached to oil droplets.
    Gray GR; Ribi E; Granger D; Parker R; Azuma I; Yamamoto K
    J Natl Cancer Inst; 1975 Sep; 55(3):727-30. PubMed ID: 1159851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Action mechanism of cell wall skeleton of BCG and Nocardia rubra as immunomodulator].
    Ogura T; Yoshimoto T; Sakatani M; Nishikawa H; Masuno T; Kawase I; Namba M; Hirao F; Yamamura Y; Itoh M
    Nihon Rinsho; 1981 Apr; 39(4):1852-60. PubMed ID: 7031297
    [No Abstract]   [Full Text] [Related]  

  • 49. [Study of unheated filtrates of cultures of mycobacteria. III. Secies specificity of dialysable components of M. bovis (BCG-Poland) filtrates and M. kansasii].
    Komorowska-Rycerz A; Szczypiorska D; Grubek H; Michalska K; Zelechowska M
    Gruzlica; 1975 Jun; 43(6):543-52. PubMed ID: 1095451
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunoadjuvant activities of cell walls and their water-soluble fractions prepared from various gram-positive bacteria.
    Kotani S; Narita T; Stewart-Tull DE; Shimono T; Watanabe Y
    Biken J; 1975 Jun; 18(2):77-92. PubMed ID: 1180872
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolation and properties of a macromolecular, water-soluble, immuno-adjuvant fraction from the cell wall of Mycobacterium smegmatis.
    Adam A; Ciorbaru R; Petit JF; Lederer E
    Proc Natl Acad Sci U S A; 1972 Apr; 69(4):851-4. PubMed ID: 4502937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Studies on the specificity and antigenic composition of fractions of Mycobacterium tuberculosis, bovine type, and Mycobacterium fortuitum. 2. Antigen-antibody reactions].
    Micke H
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Jul; 131(1):1-20. PubMed ID: 4229105
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of mycobacterial water-soluble adjuvant (MAF3) on the immune response of guinea pigs to the hapten-carrier conjugates.
    Kumazawa Y; Shibusawa A; Mizunoe K; Nakano M; Yasuhira K
    Microbiol Immunol; 1978; 22(10):655-9. PubMed ID: 105230
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect of Toxoplasma cell fractions and mycobacterial immunostimulants against virulent Toxoplasma gondii in mice.
    Masihi KN; Brehmer W; Werner H
    Zentralbl Bakteriol Orig A; 1979; 245(3):377-86. PubMed ID: 44793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Skin reactions in rabbits sensitized with typical and atypical mycobacteria and tested with homologous and heterologous protoplasm.
    Larson C; Ribi E; Baker MB; List R; Baker R; Wicht W
    Am Rev Respir Dis; 1966 Dec; 94(6):923-32. PubMed ID: 5332111
    [No Abstract]   [Full Text] [Related]  

  • 56. A comparison of the ability of protoplasm and culture filtrate (PPD) antigens from Mycobacterium tuberculosis, M. kansasii and M. batteyi to elicit delayed reactions in infected guinea pigs.
    Larson CL; Baker RE; Baker MB
    Am Rev Respir Dis; 1968 Dec; 98(6):1055-7. PubMed ID: 4972214
    [No Abstract]   [Full Text] [Related]  

  • 57. [Chemical and immunologic studies of 2 antigen active preparations with polysaccharide characteristics obtained from Mycobacterium tuberculosis and Mycobacterium bovis (BCG)].
    Klose F; Weyhers M
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Jun; 133(1):7-10. PubMed ID: 4232429
    [No Abstract]   [Full Text] [Related]  

  • 58. Rifampicin and immunosuppression.
    Nessi R; Pallanza R; Fowst G
    Arzneimittelforschung; 1974 May; 24(5):832-6. PubMed ID: 4408351
    [No Abstract]   [Full Text] [Related]  

  • 59. Effectiveness of cell walls of Mycobacterium bovis strain BCG administered by various routes and in different adjuvants in protecting mice against airborne infection with Mycobacterium tuberculosis strain H37Rv.
    Anacker RL; Barclay WR; Brehmer W; Goode G; List RH; Ribi E; Tarmina DF
    Am Rev Respir Dis; 1969 Feb; 99(2):242-8. PubMed ID: 4975012
    [No Abstract]   [Full Text] [Related]  

  • 60. CYTOPHILIC ANTIBODY IN GUINEA-PIGS WITH DELAYED-TYPE HYPERSENSITIVITY.
    BOYDEN SV
    Immunology; 1964 Jul; 7(4):474-83. PubMed ID: 14193159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.